(Q37979866)

26 August 2017

title

Cytochrome P450 variations in different ethnic populations (English)

1 reference

26 August 2017

Joseph McGraw

1

1 reference

26 August 2017

Donald Waller

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

31 January 2012

1 reference

Expert Opinion on Drug Metabolism & Toxicology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

371-382

1 reference

Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

"Cocktail" approaches and strategies in drug development: valuable tool or flawed science?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Polymorphism of human cytochrome P450 enzymes and its clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Coffee, myocardial infarction, and CYP nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Coffee, CYP1A2 genotype, and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Global variation in CYP2C8-CYP2C9 functional haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Polymorphisms of human cytochrome P450 2C9 and the functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome P450 2C19 genetic polymorphisms in Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic determinants of platelet response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Molecular basis of ethnic differences in drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pharmacogenomics of CYP3A: considerations for HIV treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Drugs as CYP3A probes, inducers, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic variability in CYP3A5 and its possible consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

CYP3A variation and the evolution of salt-sensitivity variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

New CYP2A6 gene deletion and conversion variants in a population of Black African descent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

The role of african american ethnicity and metabolism in sentinel polychlorinated biphenyl congener serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Genetic variability of CYP2B6 polymorphisms in four southern Chinese populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Pyrosequencing-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Summary of information on human CYP enzymes: human P450 metabolism data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.657626

10.1517/17425255.2012.657626

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference